Prexigebersen
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Prexigebersen
- DrugBank Accession Number
- DB17320
- Background
Not Available
- Type
- Biotech
- Groups
- Investigational
- Synonyms
- Dna, d(a-t-a-t-t-t-g-g-c-g-a-t-g-g-c-t-t-c)
- L-grb-2 antisense
- Liposomal grb2 antisense oligonucleotide
- Liposome-incorporated grb2 antisense oligodeoxynucleotide
- External IDs
- BP-100-1.01/L-GRB2
- BP-1001
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 8W1O4Y961B
- CAS number
- 202484-91-1
References
- General References
- Not Available
- External Links
- Not Available
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Recruiting Treatment Acute Myeloid Leukemia 1 1 Completed Treatment Acute Lymphoblastic Leukemia (ALL) / Myelodysplastic Syndrome / Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML) / Recurrent Adult Acute Myeloid Leukemia 1 1 Recruiting Treatment Adult Solid Tumor / Endometrial Cancer / Epithelial Ovarian Cancer / Fallopian Tube Neoplasms / Peritoneal Cancer / Solid Tumors 1 1, 2 Withdrawn Treatment Acute Myeloid Leukemia / Chronic Myelogenous Leukemia, Ph1-Positive / Myelodysplastic Syndrome 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 05, 2022 21:20 / Updated at December 06, 2022 13:40